skip to main content

Lowenstein Sandler LLP | The contents of this website contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.

Search
Smart Search Icon
Header Search
view all search results
Search Close
Hamburger
profile Icon for Mobile

Robert J. Paradiso

Partner
Chair, Life Sciences & Chemical Patent Practice

New Jersey
T: +1 973.597.2404 F: +1 973.597.2405 rparadiso@lowenstein.com
  • BIO
  • EXPERIENCE
  • HONORS & AWARDS
  • NEWS & INSIGHTS

See more section

Robert Paradiso's practice is focused on the life sciences and chemical industries. Over the course of his career, he has counseled clients on the discovery, design, and protection of many successful therapeutic and diagnostic products with important commercial and humanitarian benefits. 

As a registered pharmacist, Robert is able to speak the same language as the researchers, managers, and investors with whom he interacts daily. He is particularly adept at analyzing complex issues and effectively crafting, communicating, and implementing solutions that achieve his clients' goals–whether for raising capital, closing the deal, or obtaining a bet-the-company patent.

Clients benefit from Robert's significant experience in virtually all aspects of intellectual property law, including:

  • Patent prosecution
  • Noninfringement
  • Patentability
  • Litigation
  • Freedom to operate
  • Technology transfer

He also regularly advises clients on product acquisition and divestiture, joint ventures and alliances, technology licensing, outsourcing, and other technology-related transactions.

Robert serves as an adjunct professor at Seton Hall University School of Law, where he teaches patent drafting and prosecution.

  • Obtained a groundbreaking patent that is listed in the FDA Orange Book for a tamper-resistant formulation of an FDA-approved narcotic analgesic.
  • Obtained Orange Book-listed patents for a specialty pharmaceutical company specializing in acute hospital care. The patents encompass four currently marketed formulations of an injectable antihypertensive product and were the driving force for the eventual acquisition of the company.
  • Obtained multiple patents covering a Phase III injectable product for the treatment of adverse effects of chemotherapy.
  • Represented a leading U.S. medical school in prosecuting and procuring patents directed to specialized tests that are capable of detecting latent tuberculosis in patients.
  • Performed an IP analysis for a leading financial services firm in connection with an investment in a biopharmaceutical company developing a genetically personalized therapeutic agent.

 

  • Obtained multiple patents covering a Phase III injectable product for the treatment of adverse effects of chemotherapy.
  • Obtained a groundbreaking patent that is listed in the FDA Orange Book for a tamper-resistant formulation of an FDA-approved narcotic analgesic.
  • Obtained Orange Book-listed patents for a specialty pharmaceutical company specializing in acute hospital care. The patents encompass four currently marketed formulations of an injectable antihypertensive product and were the driving force for the eventual acquisition of the company.
SEE MORE

CLICK HERE FOR AWARD INFORMATION & METHODOLOGY

No aspect of these advertisements has been approved by the highest court of any state.

Education

  • St. John's University School of Law (J.D. 1994)

    Long Island University (B.S. 1990), Pharmacy

Admissions

  • New York
  • New Jersey
  • United States Patent and Trademark Office

Related Areas

Additional Resources

Additional Resources

Subscribe